Immunohistochemical expression of p16INK4A protein as a helpful marker of a subset of potentially malignant oral epithelial lesions: Study on a series with long-term follow-up

Histopathology

Volumn 57, Issue 4, 2010, Pages 528-534

  Montebugnoli, Lucio ^a   Cervellati, Fabio ^a   Cocchi, Roberto ^b   Farnedi, Anna ^a   Pennesi, Maria Gabriella ^b   Flamminio, Federica ^a   Foschini, Maria Pia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

Immunohistochemistry; Oral lesions; OSCC; P16INK4A

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ANALYSIS OF VARIANCE; ARTICLE; BIOPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MOUTH CARCINOMA; MOUTH LESION; MOUTH MUCOSA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; STAINING;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650453792     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03671.x     Document Type: Article

References (47)

1. Califano J, Van Der Riet P, Westra W et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996; 6; 2488-2492.
2. Reshmi SC, Saunders WS, Kudla DM, Ragin CR, Gollin SM. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes Chromosomes Cancer 2004; 41; 38-46.
3. El-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res. 1995; 55; 2656-2659.
4. Van Der Riet P, Nawroz H, Hruban RH et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 1994; 54; 1156-1158.
5. Nawroz H, Van Der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 1994; 54; 1152-1155.
6. Todd R, Hinds PW, Munger K et al. Cell cycle dysregulation in oral cancer. Crit. Rev. Oral Biol. Med. 2002; 13; 51-61.
7. Muirhead DM, Hoffman HT, Robinson RA. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma. J. Clin. Pathol. 2006; 59; 711-715.
8. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1998; 1378; F115-F177.
9. Nagpal JK, Das BR. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol. 2003; 39; 213-221.
10. Yuen PW, Man M, Lam KY, Kwong YL. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J. Clin. Pathol. 2002; 55; 58-60.
11. Ai L, Stephenson KK, Ling W et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod. Pathol. 2003; 16; 944-950.
12. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp. Cell Res. 2001; 264; 42-55.
13. Weinberger PM, Yu Z, Haffty BG et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin. Cancer Res. 2004; 10; 5684-5691.
14. Namazie A, Alavi S, Olopade OI et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 2002; 112; 472-481.
15. Karsai S, Abel U, Roesch-Ely M et al. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J. Pathol. 2007; 211; 314-322.
16. Paradiso A, Ranieri G, Stea B et al. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Int. J. Oncol. 2004; 24; 249-255.
17. Nemes JA, Deli L, Nemes Z, Márton IJ. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral. Surg. Oral Med. Oral Pathol.Oral Radiol. Endod. 2006; 102; 344-352.
18. Buajeeb W, Poomsawat S, Punyashing J, Sanguansin S. Expression of p16 in oral cancer and premalignant lesions. J. Oral Pathol. Med. 2009; 38; 104-108.
19. Klaes R, Friedrich T, Spitkovsky D et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 2001; 92; 276-284.
20. Klaes R, Benner A, Friedrich T et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol. 2002; 26; 1389-1399.
21. Sano T, Masuda N, Oyama T, Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol. Int. 2002; 52; 375-383.
22. Murphy N, Ring M, Heffron CC et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J. Clin. Pathol. 2005; 58; 525-534.
23. Regauer S, Reich O. CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology 2007; 50; 629-635.
24. Papadimitrakopoulou V, Izzo J, Lippman SM et al. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 1997; 14; 1799-1803.
25. Kresty LA, Mallery SR, Knobloch TJ et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 2002; 62; 5295-5300.
26. Gologan O, Barnes EL, Hunt JL. Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am. J. Surg. Pathol. 2005; 29; 792-796.
27. Cunningham LL Jr, Pagano GM, Li M et al. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006; 102; 77-81.
28. Bradley KT, Budnick SD, Logani S. Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity. Mod. Pathol. 2006; 19; 1310-1316.
29. El Naggar AK, Reichart PA. Proliferative verrucous leukoplakia and precancerous conditions. In Barnes L, Eveson JW, Reichart P, Sidranski D eds. Pathology and genetics head and neck tumour. Lyon: World Health Classification of Tumours, 2005; 180-181.
30. Nakahara Y, Shintani S, Mihara A, Ueyama Y, Matsamura T. Alterations of Rb, p16INK4a and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett. 2000; 160; 3-8.
31. Li Y, Nichols MA, Shay JW, Xiong Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 1994; 54; 6078-6682.
32. Cairns P, Polascik TJ, Eby Y et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 1995; 11; 210-212.
33. Zhang SY, Klein-Szanto AJ, Sauter ER et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 1994; 54; 5050-5053.
34. Merlo A, Herman JG, Mao L et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1995; 1; 686-692.
35. Campisi G, Panzarella V, Giuliani M et al. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int. J. Oncol. 2007; 30; 813-823.
36. Wong TS, Man MW, Lam AK, Wei WI, Kwong YL, Yuen AP. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur. J. Cancer 2003; 39; 1881-1887.
37. Balaram P, Nalinakumari KR, Abraham E et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int. J. Cancer 1995; 61; 450-454.
38. Miguel RE, Villa LL, Cordeiro AC, Prado JC, Sobrinho JS, Kowalski LP. Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am. J. Surg. 1998; 176; 428-429.
39. Braakhuis BJ, Snijders PJ, Keune WJ et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J. Natl Cancer Inst. 2004; 96; 998-1006.
40. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002; 21; 1510-1517.
41. Hafkamp HC, Speel EJ, Haesevoets A et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int. J. Cancer 2003; 107; 394-400.
42. Fregonesi PA, Teresa DB, Duarte RA, Neto CB, De Oliveira MR, Soares CP. p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J. Histochem. Cytochem. 2003; 51; 1291-1297.
43. Heinzel PA, Balaram P, Bernard HU. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int. J. Cancer 1996; 68; 420-423.
44. Koo CL, Kok LF, Lee MY et al. Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. J. Transl. Med. 2009; 14; 7-25.
45. Hall GL, Shaw RJ, Field EA et al. P16 promoter hypermethylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol. Biomarkers Prev. 2008; 17; 2174-2179.
46. Grüttgen A, Reichenzeller M, Jünger M, Schlien S, Affolter A, Bosch FX. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers. J. Pathol. 2001; 194; 311-317.
47. Pande P, Mathur M, Shukla NK, Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol. 1998; 34; 396-403.